Filing Flows

Filing Flows › Financials › Trupanion (TRUP)

Trupanion (TRUP) earnings and revenue breakdown

Latest: Q3 2026 · 10-Q filed Nov 5, 2026 · Trupanion (TRUP) Q3 2026 earnings results →

Q3 2026 Revenue up 10% year over year to $406M · 2¢ of every $1 of revenue kept as net profit · operating margin 2.4%

Trupanion made $406M in Q3 2026 (+10% Y/Y): Subscription business $288M, Other Segments $118M. Operating margin 2.4%, net earnings $9.3M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Nov 5, 2026.

Revenue$406M
Year over year+10%
Operating margin2.4%
Net earnings$9.3M
Operating cash flow$30.7M

Drawing the Sankey…

Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF

What changed this quarter

Revenue was $405.6M in Q3 2026, up 11% year over year and up 3% from the previous quarter. Subscription business was the largest line at 71% of revenue. Subscription business added $35.2M year over year (up 14%), 91% of the total change.

Operating profit was $9.5M, a 2.4% margin (up 0.8 points year over year). Of the extra revenue versus Q3 2025, 10% reached operating profit, above the 2% margin then. Total costs grew 10% against revenue growth of 11%. The fastest-growing cost line was Other operating costs (+17%). Net earnings were $9.3M, up 58% year over year. The effective tax rate was 9.4%.

Operating cash flow was $30.7M (up 5% year over year), 331% of net earnings. Non-cash charges added back $3.8M of depreciation and amortization and $8.1M of share-based compensation. Working capital and other items added $9.6M. After purchases of property, equipment, and internal-use software ($2.2M), free cash flow as the company reports it was $28.5M.

Quarterly history

Trupanion revenue by quarterTrupanion revenue by quarter$342MQ1 2025$354MQ2 2025$367MQ3 2025$377MQ4 2025$384MQ1 2026$393MQ2 2026$406MQ3 2026
Trupanion net earnings by quarterTrupanion net earnings by quarter−$1.5MQ1 2025$9.4MQ2 2025$5.9MQ3 2025$5.6MQ4 2025$4.9MQ1 2026$6.8MQ2 2026$9.3MQ3 2026
QuarterFormFiledRevenueY/YOp. marginNet earningsOp. cash flow
Q3 202610-QNov 5, 2026$406M+10%2.4%$9.3M$30.7M
Q2 202610-QAug 5, 2026$393M+11%1.6%$6.8M$21.0M
Q1 202610-QApr 30, 2026$384M+12%1.2%$4.9M$14.6M
Q4 202510-KFeb 13, 2026$377M+12%1.9%$5.6M$29.3M
Q3 202510-QNov 6, 2025$367M+12%1.6%$5.9M$29.2M
Q2 202510-QAug 7, 2025$354M+12%0.7%$9.4M$15.0M
Q1 202510-QMay 1, 2025$342M+12%-0.4%−$1.5M$16.0M

Charts

Trupanion: revenue growth, year over year and quarter over quarterTrupanion: revenue growth, year over year and quarter over quarterY/YQ/Q+12%Q1 2025+12%+3%Q2 2025+12%+4%Q3 2025+12%+3%Q4 2025+12%+2%Q1 2026+11%+2%Q2 2026+10%+3%Q3 2026
Latest (Q3 2026): Y/Y +10%, Q/Q +3%.
Trupanion: where the cash came from (+) and went (−), TTM to Q3 2026Trupanion: where the cash came from (+) and went (−), TTM to Q3 2026Operating cash flow$95.6MOther investing−$37.1MOther financing−$37.0MCash drawn (+) / kept (−)−$10.6MCapital spending−$8.8MTaxes on employees’ shares−$2.5MShares issued$1.1MExchange rates−$595K
From the cash-flow statement as filed (SEC XBRL). Cash is fungible: the bars do not say which dollar paid for what.
Trupanion: profit against cash, quarter by quarterTrupanion: profit against cash, quarter by quarterNet incomeOperating cash flow$1.7M$23.7MQ4 2024−$1.5M$16.0MQ1 2025$9.4M$15.0MQ2 2025$5.9M$29.2MQ3 2025$5.6M$29.3MQ4 2025$4.9M$14.6MQ1 2026$6.8M$21.0MQ2 2026$9.3M$30.7MQ3 2026
Latest (Q3 2026): Net income $9.3M, Operating cash flow $30.7M.
Trupanion: diluted shares by fiscal yearTrupanion: diluted shares by fiscal year36MFY202040MFY202141MFY202241MFY202342MFY202444MFY2025
+21.5% since FY2020: more shares outstanding (issuance, stock pay).
Trupanion: long-term debt falling due (FY2025)Trupanion: long-term debt falling due (FY2025)$10.0M2027$10.0M2028$92.5M2029
Cash $138M, short-term investments $233M, long-term debt $102M at 2025-12-31.
Trupanion in its industry: growth against margin (10 companies, SIC 6324)Trupanion in its industry: growth against margin (10 companies, SIC 6324)revenue growth, year over year →↑ operating marginmedian +10%median 2%UNHCIELVCNCHUMMOHOSCRALHCCLOVTRUP (+10%, 2%)
Hospital & Medical Service Plans; dot size is quarterly revenue; dashed lines are the industry's medians.

Interactive views

The same charts as the app — open one to draw it.

💵Where each $1 goesinteractive

Loading the interactive chart…

🌏Named in Asian annual reportsinteractive

Loading the interactive chart…

🔄Rotation against the market and its industry (RRG)interactive

Loading the interactive chart…

🔍Earnings qualityinteractive

Loading the interactive chart…

⚖️Fair value by methodinteractive

Loading the interactive chart…

🔭Outlook & guidanceinteractive

Loading the interactive chart…

📈Investments: gains and what it boughtinteractive

Loading the interactive chart…

🏭Its industry’s money flow (input-output)interactive

Loading the interactive chart…

About Trupanion

We provide medical insurance for cats and dogs in the United States, Canada, and certain countries in Continental Europe. Through our data-driven, vertically-integrated approach, we develop and offer high-value medical insurance products, priced to take into account each pet’s unique characteristics and coverage level. Our growing and loyal membership base provides us with highly predictable and recurring revenue. We operate in two reporting segments: subscription business and other business. We generate revenue in our subscription business segment primarily through insurance premiums, which we refer to as subscription payments, from direct-to-consumer products.

In its own words, from its 10-K, filed Feb 13, 2026.

Trupanion against its Hospital & Medical Service Plans peers

The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: +10% against the peers' median +6%. Operating margin: 2.4% against the peers' median 2.4%.

CompanyQuarterRevenueY/YOp. margin
TRUP TrupanionQ3 2026$406M+10%2.4%
UNH UnitedHealth GroupQ3 2026$112.7B-0.4%5.8%
CI CignaQ3 2026$73.7B+6%3.3%
ELV Elevance HealthQ3 2026$51.4B+1%2.5%
CNC CenteneQ3 2026$50.6B+2%-0.6%
HUM HumanaQ3 2026$41.2B+26%0.2%
MOH Molina HealthcareQ3 2026$11.1B-3%1.0%
OSCR Oscar HealthQ3 2026$5.1B+72%3.5%
ALHC Alignment HealthcareQ3 2026$1.4B+37%-0.3%

Source: Trupanion 10-Q on SEC EDGAR · CIK 1371285 · Hospital & Medical Service Plans

Guidance and outlook

Trupanion: what its forward-looking statements are about (10-Q filed 2026-11-05)Trupanion: what its forward-looking statements are about (10-Q filed 2026-11-05)Margins6Other6Costs5Demand2Products1Legal & regulation1
21 statements; tone +0.10 (−1 all cautious, +1 all confident); 5 hedged.
Trupanion: outlook statements against the filing beforeTrupanion: outlook statements against the filing beforeConfident6Cautious4

13F: who owns TRUP and who is buying

Largest holders of TRUP (13F)Largest holders of TRUP (13F)BlackRock$135MVanguard Group$131MCapital World Investors$95.1MAflac$90.1MVanguard Portfolio Management LLC$44.6MPolar Capital Holdings$43.3MVanguard Capital Management LLC$36.8MState Street$33.8MFMR LLC$25.8MMorgan Stanley$22.3M
Funds' net buying of TRUP by quarter (13F)Funds' net buying of TRUP by quarter (13F)−$34.2M2024-09−$108M2024-12$31.0M2025-03−$17.6M2025-06−$62.2M2025-09−$68.0M2025-12−$63.8M2026-03$2.2M2026-06
Value of shares 13F filers added minus the value they sold, each quarter (quarters with most filings in).

More on TRUP

History

Every quarter: Q3 2026 results · Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results

Compare TRUP with

中文版:Trupanion(TRUP)财报

Español · Français